Former US President Joe Biden’s prostate cancer has advanced and metastasized to his bones, his wife Jill Biden said while sharing an update on his health.Biden was diagnosed with an “aggressive form” of prostate cancer in May 2025. Later, he was also diagnosed with skin cancer. During an interview on NBC's Today to promote her new memoir, the former first lady said Biden is “doing OK” despite his ongoing battle with prostate cancer. She added that Joe Biden will live with cancer for the rest of his life.“He’s doing OK,” she said. “I think if he had just been diagnosed with prostate cancer, that’s one thing because that can be cured, but the fact that it metastasized to his bones, that makes it a whole different story," Jill added. "And so I think Joe will live with cancer the rest of his life.”In October 2025, the former President underwent radiation therapy. He was also being treated with hormone therapy. In September 2025, Biden’s spokesperson also announced that the 83-year-old had surgery to treat skin cancer.Joe Biden was diagnosed with prostate cancer after “experiencing urinary symptoms,” according to a statement released in May 2025. Doctors found a “small nodule” on his prostate during an examination.Prostate cancer is the second most common cancer among men, affecting about one in eight men in the United States, according to the American Cancer Society.What Is The Prostate And How Is Screening Done?Also read: Benjamin Netanyahu Undergoes Treatment For Early-stage Prostate Cancer The prostate is a small walnut-shaped gland in men that produces seminal fluid, which nourishes and transports sperm. Prostate cancer develops when abnormal cells begin growing in the gland.Dr. Srikanth Munna, Consultant Urology, Andrologist, Laparoscopy and Penile Implant Surgeon at KIMS Hospital, Hyderabad, told HealthandMe that prostate cancer is one of the most common cancers in men and involves the abnormal growth of cells in the gland.Importantly, if detected early, it is often curable. Age, family history, and lifestyle factors are among the most common risk factors.Prostate cancer treatment guidelines have evolved in recent years, with many men opting for active surveillance rather than immediate treatment for slow-growing tumors.However, about 50 per cent of men on “watchful waiting” may require further treatment within five years because of tumor progression. A simple Prostate-Specific Antigen (PSA) blood test can help assess risk, Dr Munna said.Read More: Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer TreatmentThe expert noted that some early-stage symptoms of the disease include:Blood in the urine or semenTrouble urinatingErectile dysfunctionMore advanced prostate cancer may cause symptoms such as:Decreased force in the urine streamBone painUnexplained weight lossRead: Prostate Cancer Screening In UK To Focus On High-Risk Men; Guidelines Reject Universal TestingExperts say not all prostate cancers are life-threatening. Some forms grow very slowly and may never affect a man’s lifespan. Such slow-growing cancers are found in around one in three men over the age of 50.However, a smaller number of prostate cancers are aggressive, spread rapidly, and can become life-threatening, making timely detection important.While screening is done via a blood test called PSA, it can sometimes lead to overdiagnosis and unnecessary treatment, and may result in side effects such as erectile dysfunction and loss of bladder control in healthy men.